Between 2014 and 2023, Medicare reimbursement for TAA declined markedly for foot and ankle surgeons. Continued reductions in Medicare payments may threaten practice sustainability and patient access to specialized foot and ankle reconstructive care.
Ferdon et al. (Wed,) studied this question.